Logo image of NINE

NINE ENERGY SERVICE INC (NINE) Stock Fundamental Analysis

NYSE:NINE - New York Stock Exchange, Inc. - US65441V1017 - Common Stock - Currency: USD

0.517  -0.01 (-2.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NINE. NINE was compared to 63 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of NINE have multiple concerns. NINE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NINE has reported negative net income.
NINE had a positive operating cash flow in the past year.
In the past 5 years NINE reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NINE reported negative operating cash flow in multiple years.
NINE Yearly Net Income VS EBIT VS OCF VS FCFNINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.16%, NINE is doing worse than 84.13% of the companies in the same industry.
With a Return On Invested Capital value of 3.20%, NINE is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for NINE is below the industry average of 8.65%.
Industry RankSector Rank
ROA -11.16%
ROE N/A
ROIC 3.2%
ROA(3y)-5.35%
ROA(5y)-23.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.77%
ROIC(5y)N/A
NINE Yearly ROA, ROE, ROICNINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

NINE has a worse Operating Margin (1.97%) than 82.54% of its industry peers.
NINE's Operating Margin has improved in the last couple of years.
NINE's Gross Margin of 17.65% is on the low side compared to the rest of the industry. NINE is outperformed by 76.19% of its industry peers.
In the last couple of years the Gross Margin of NINE has declined.
Industry RankSector Rank
OM 1.97%
PM (TTM) N/A
GM 17.65%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.04%
GM growth 5Y-2.13%
NINE Yearly Profit, Operating, Gross MarginsNINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NINE is destroying value.
NINE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NINE has been increased compared to 5 years ago.
The debt/assets ratio for NINE is higher compared to a year ago.
NINE Yearly Shares OutstandingNINE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NINE Yearly Total Debt VS Total AssetsNINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

NINE has an Altman-Z score of -1.41. This is a bad value and indicates that NINE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.41, NINE is doing worse than 88.89% of the companies in the same industry.
NINE has a debt to FCF ratio of 91.86. This is a negative value and a sign of low solvency as NINE would need 91.86 years to pay back of all of its debts.
NINE has a worse Debt to FCF ratio (91.86) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 91.86
Altman-Z -1.41
ROIC/WACC0.29
WACC11.12%
NINE Yearly LT Debt VS Equity VS FCFNINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

NINE has a Current Ratio of 2.03. This indicates that NINE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NINE (2.03) is better than 61.90% of its industry peers.
NINE has a Quick Ratio of 1.43. This is a normal value and indicates that NINE is financially healthy and should not expect problems in meeting its short term obligations.
NINE has a Quick ratio (1.43) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.43
NINE Yearly Current Assets VS Current LiabilitesNINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2

3. Growth

3.1 Past

NINE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.33%.
The Revenue has decreased by -4.38% in the past year.
The Revenue has been decreasing by -7.83% on average over the past years.
EPS 1Y (TTM)-8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-4.38%
Revenue growth 3Y16.62%
Revenue growth 5Y-7.83%
Sales Q2Q%5.87%

3.2 Future

NINE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.78% yearly.
NINE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.38% yearly.
EPS Next Y13.76%
EPS Next 2Y5.79%
EPS Next 3Y9.78%
EPS Next 5YN/A
Revenue Next Year2.93%
Revenue Next 2Y1.18%
Revenue Next 3Y2.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NINE Yearly Revenue VS EstimatesNINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
NINE Yearly EPS VS EstimatesNINE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

2

4. Valuation

4.1 Price/Earnings Ratio

NINE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NINE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NINE Price Earnings VS Forward Price EarningsNINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

NINE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NINE is more expensive than 69.84% of the companies in the same industry.
NINE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NINE is cheaper than 84.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.26
EV/EBITDA 6.96
NINE Per share dataNINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.79%
EPS Next 3Y9.78%

0

5. Dividend

5.1 Amount

No dividends for NINE!.
Industry RankSector Rank
Dividend Yield N/A

NINE ENERGY SERVICE INC

NYSE:NINE (5/29/2025, 2:29:06 PM)

0.517

-0.01 (-2.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners28.91%
Inst Owner Change-16.64%
Ins Owners30.69%
Ins Owner Change1.09%
Market Cap21.89M
Analysts40
Price Target1.02 (97.29%)
Short Float %10.04%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.76%
Min EPS beat(2)-17.65%
Max EPS beat(2)10.13%
EPS beat(4)2
Avg EPS beat(4)1.86%
Min EPS beat(4)-17.65%
Max EPS beat(4)18.3%
EPS beat(8)5
Avg EPS beat(8)3.65%
EPS beat(12)7
Avg EPS beat(12)122.57%
EPS beat(16)9
Avg EPS beat(16)91.93%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-1.13%
Max Revenue beat(2)2.94%
Revenue beat(4)2
Avg Revenue beat(4)-0.17%
Min Revenue beat(4)-3.13%
Max Revenue beat(4)2.94%
Revenue beat(8)2
Avg Revenue beat(8)-1.38%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)6
Avg Revenue beat(16)-0.12%
PT rev (1m)-20%
PT rev (3m)0%
EPS NQ rev (1m)-120%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)-57.63%
EPS NY rev (3m)-24%
Revenue NQ rev (1m)-5.41%
Revenue NQ rev (3m)4.06%
Revenue NY rev (1m)-5.85%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF 6.26
P/OCF 1.31
P/B N/A
P/tB N/A
EV/EBITDA 6.96
EPS(TTM)-1.04
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)0.08
FCFY15.98%
OCF(TTM)0.4
OCFY76.52%
SpS13.28
BVpS-1.7
TBVpS-3.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.16%
ROE N/A
ROCE 4.06%
ROIC 3.2%
ROICexc 3.42%
ROICexgc 4.88%
OM 1.97%
PM (TTM) N/A
GM 17.65%
FCFM 0.62%
ROA(3y)-5.35%
ROA(5y)-23.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.77%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)9.03%
ROICexgc(5y)N/A
ROCE(3y)7.3%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y1.45%
ROICexc growth 3YN/A
ROICexc growth 5Y15.27%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.04%
GM growth 5Y-2.13%
F-Score3
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 91.86
Debt/EBITDA 6.8
Cap/Depr 36.95%
Cap/Sales 2.36%
Interest Coverage 0.25
Cash Conversion 35.68%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.43
Altman-Z -1.41
F-Score3
WACC11.12%
ROIC/WACC0.29
Cap/Depr(3y)57.21%
Cap/Depr(5y)45.01%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y13.76%
EPS Next 2Y5.79%
EPS Next 3Y9.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.38%
Revenue growth 3Y16.62%
Revenue growth 5Y-7.83%
Sales Q2Q%5.87%
Revenue Next Year2.93%
Revenue Next 2Y1.18%
Revenue Next 3Y2.38%
Revenue Next 5YN/A
EBIT growth 1Y-32.17%
EBIT growth 3YN/A
EBIT growth 5Y-6.04%
EBIT Next Year478.5%
EBIT Next 3Y85.85%
EBIT Next 5YN/A
FCF growth 1Y151.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.4%
OCF growth 3YN/A
OCF growth 5Y-33.48%